Suppliers / Bard Pharmaceuticals

Bard Pharmaceuticals

United Kingdom Updated 9 July 2026

Bard Pharmaceuticals is a finished-dose manufacturer based in United Kingdom. It appears in 30 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with NPRA (MY), EDE (AE) and Health Canada. Its GMP standing is certified by MHRA (UK) and ANVISA (Brazil).

0
active US DMFs
0
valid CEPs
2
registered plants
30
filings across 6 regulators

Registered plants

Site FDA FEI
CAMBRIDGE, United Arab Emirates Not on file
CAMBRIDGE, United Kingdom Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
NPRA (MY) 9 None
EDE (AE) 8 None
Health Canada 5 None
ARCSA (EC) 4 None
MINSA (CR) 3 None
DAV (Vietnam) 1 None
MHRA (UK) None 4
ANVISA (Brazil) None 2

Comparing suppliers?

Choose your molecules and target markets. Bard Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates